Friday, 17 Nov 2017

You are here

Dr. Janet Pope: JAK 2 Inhibitor Controversy

Dr. Janet Pope talks about JAK 2 inhibitors and increased VTE as presented at the ACR/ARHP Annual Meeting in San Diego.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
ACR VIDEO

Alvin Wells, MD: JAK Inhibitors, Other...

08 Nov 2015

RheumNow Week in Review – 22 April 2016

22 Apr 2016

The RheumNow Week in Review - 26 May...

26 May 2017

Dr. Arthur Kavanaugh: Rheumatology...

07 Nov 2017

15 September 2017 The RheumNow Week in...

15 Sep 2017

RWCS 2017: Current State of the Art in...

24 Feb 2017

Dr. Orrin Troum, MD: Interested in...

09 Nov 2015

Dr. Kathryn Dao: Evidence of Prior...

06 Nov 2017

Bernard Rubin, DO: The Knowledge Bowl!

10 Nov 2015

The RheumNow Week in Review – 10...

10 Feb 2017

Dr. Julie Jones: Sporadic Late Onset...

02 Mar 2016

Dr. Rachel T. Huston: Cardiovascular...

08 Dec 2016